Simvastatin Alleviation of Trimethyltin‐Induced Hippocampal and Behavioral Impairments via Improvement of Antioxidants, Mitochondrial Health, and Energy Homeostasis

ABSTRACT Mitochondrial dysfunction and antioxidant deficiency are key contributors to the pathogenesis of Alzheimer's disease (AD). Trimethyltin (TMT) induces selective hippocampal damage associated with redox disequilibrium, neuroinflammatory responses, mitochondrial dysfunction, and impaired energy homeostasis, leading to cognitive decline. The present study evaluated whether simvastatin as a lipid‐lowering and protective medicine could mitigate TMT‐induced behavioral abnormalities by improving hippocampal antioxidant status, mitochondrial integrity, and energy homeostasis. Rats were assigned to control, control + simvastatin (30 mg/kg), TMT, TMT + simvastatin (10 mg/kg), and TMT + simvastatin (30 mg/kg) groups. TMT was injected IP (once, 8 mg/kg) to instigate neurotoxicity. Following three weeks of treatment, locomotor activity and conditioned learning and memory deficits were analyzed using open‐field and passive avoidance tests, respectively. Besides, hippocampal levels or activity of nitrite, glutathione (GSH), glutathione peroxidase (GPx), myeloperoxidase (MPO), and β‐site APP‐cleaving enzyme 1 (BACE1), mitochondrial membrane potential (MMP), and AMP‐activated protein kinase (AMPK) were measured. Simvastatin treatment (30 mg/kg) was associated with higher latency in the passive avoidance test and longer rearing in the open field test in TMT‐intoxicated rats. Additionally, simvastatin improved hippocampal GSH, GPx, MMP, and AMPK and mitigated MPO activity relative to the TMT group but did not significantly affect nitrite or BACE‐1 activity. Collectively, simvastatin mitigated TMT‐induced neurobehavioral impairment, partly through restoration of antioxidants and mitochondrial health in association with AMPK.

Authors

Institutions

Publication Details

Journal
Pharmacology Research & Perspectives
Published
2026-11-15
DOI
https://doi.org/10.1002/prp2.70352
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Simvastatin Alleviation of Trimethyltin‐Induced Hippocampal and Behavioral Impairments via Improvement of Antioxidants, Mitochondrial Health, and Energy Homeostasis

Mohsen Khalili, Adel Salari Esker, Mahdieh Taheri, Mehrdad Roghani
Pharmacology Research & Perspectives
Alzheimer's disease research and treatments
article

Simvastatin Alleviation of Trimethyltin‐Induced Hippocampal and Behavioral Impairments via Improvement of Antioxidants, Mitochondrial Health, and Energy Homeostasis

Mohsen Khalili, Adel Salari Esker, Mahdieh Taheri, Mehrdad Roghani
article en

Abstract

ABSTRACT Mitochondrial dysfunction and antioxidant deficiency are key contributors to the pathogenesis of Alzheimer's disease (AD). Trimethyltin (TMT) induces selective hippocampal damage associated with redox disequilibrium, neuroinflammatory responses, mitochondrial dysfunction, and impaired energy homeostasis, leading to cognitive decline. The present study evaluated whether simvastatin as a lipid‐lowering and protective medicine could mitigate TMT‐induced behavioral abnormalities by improving hippocampal antioxidant status, mitochondrial integrity, and energy homeostasis. Rats were assigned to control, control + simvastatin (30 mg/kg), TMT, TMT + simvastatin (10 mg/kg), and TMT + simvastatin (30 mg/kg) groups. TMT was injected IP (once, 8 mg/kg) to instigate neurotoxicity. Following three weeks of treatment, locomotor activity and conditioned learning and memory deficits were analyzed using open‐field and passive avoidance tests, respectively. Besides, hippocampal levels or activity of nitrite, glutathione (GSH), glutathione peroxidase (GPx), myeloperoxidase (MPO), and β‐site APP‐cleaving enzyme 1 (BACE1), mitochondrial membrane potential (MMP), and AMP‐activated protein kinase (AMPK) were measured. Simvastatin treatment (30 mg/kg) was associated with higher latency in the passive avoidance test and longer rearing in the open field test in TMT‐intoxicated rats. Additionally, simvastatin improved hippocampal GSH, GPx, MMP, and AMPK and mitigated MPO activity relative to the TMT group but did not significantly affect nitrite or BACE‐1 activity. Collectively, simvastatin mitigated TMT‐induced neurobehavioral impairment, partly through restoration of antioxidants and mitochondrial health in association with AMPK.

Pharmacology Research & PerspectivesVol. 14(6)
Shahed University (IR), Kharazmi University (IR)
Alzheimer's disease research and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon